$MDAI

Spectral AI, Inc. (MDAI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Spectral AI, Inc. (MDAI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-99.1 2 ea029741201ex99-1.htm OFFER LETTER, BY AND BETWEEN DARCY BAJKO AND SPECTRAL AI, INC., DATED JULY 7, 2026 Exhibit 99.1 Darcy L. Bajko Cleveland, OH Re: Offer of Employment Dear Darcy, Spectral AI, Inc. (the “ Company ”) is pleased to make an offer of employment as Chief

Original reporting
Published Jul 8, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 8:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MDAI
Neutral
medium confidence
Mentioned
$MDAI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MDAINeutralLow
01

Why it matters

This is primarily a corporate governance and compensation disclosure. It can modestly affect sentiment around go-to-market execution, but it does not provide new financial performance, contract awards, or guidance.

02

Market read

A fresh executive appointment with defined pay and option terms, but no immediate commercial or financial metrics.

03

What to watch

Traders should watch for follow-on disclosures tied to this hire, such as new customer contracts, pipeline updates, or updated guidance, none of which appear in the provided text.

Relevance 6/10Novelty 4/10Timing: Filed after-hours on 2026-07-08, reflecting a fresh executive appointment disclosure.

Background

The SEC 8-K (Item 5.02) includes an offer letter for a new Chief Commercial Officer, including compensation and equity grant details subject to board approval.

Company-level read

Ticker impact

$MDAINeutralMedium confidence
Context

Spectral AI disclosed an 8-K offer letter appointing Darcy Bajko as Chief Commercial Officer with $315,000 salary and up to 150,000 options.

Expected impact

Likely limited near-term impact; any reaction would be small and sentiment-driven unless paired with guidance or major commercial wins.

Evidence & confidence

The filing is an executive hiring/compensation disclosure (Item 5.02) with no revenue, margin, or guidance numbers. Such events can move micro/small caps slightly, but the text provides no new business outcome.

Market effects

No direct sector read-across; this is an internal commercial leadership change.

None indicated.

None indicated.

Counterpoint

The appointment may reflect internal restructuring or a gap in commercial execution rather than a growth catalyst, so the market may discount it quickly.

Key entities

  • Spectral AI, Inc.

    Company filing the 8-K and offering employment to a new Chief Commercial Officer.

  • Darcy L. Bajko

    Named in the offer letter as Chief Commercial Officer, with specified salary, bonus eligibility, and potential option grant.

  • Vince Capone

    CEO to whom the new CCO will report, referenced in the offer letter.

Related articles

$MDAIMed

Spectral AI, Inc. (MDAI): Results of Operations and Financial Condition

Spectral AI, Inc. (MDAI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Spectral AI Announces 2026 Second Quarter Financial Results Company Continues to Advance Towards First Commercial Sales of the DeepView ® System for Burn Indication Strong Cash Position of $14.0 Million at June 30, 2026 DALLAS, TX – August 11, 2026 – Spectral AI, Inc

$MDAIMed

Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication

Spectral AI, Inc. (Nasdaq: MDAI) appointed Darcy Bajko as Chief Commercial Officer effective July 31, 2026, to lead global sales for its FDA De Novo-cleared DeepView System for burn indication. The company said it aims to close its first commercial sales by year end 2026 and target adoption in US burn centers and emergency departments.

$PHOSMed

First Phosphate shareholders could see reduced dilution risk, Noble says after SERV news

First Phosphate Corp. (PHOS) may face reduced equity dilution after Noble Capital Markets noted potential lower funding needs for its Bégin-Lamarche project, supported by Swiss Export Risk Insurance (SERV) and other financing. SERV could provide up to US$212.5 million, reducing the equity requirement to about US$82.5 million. Noble maintains an Outperform rating and $25.50 price target.

$AONHighAI 9/10

Aon raises $13.75 billion to support USI acquisition

Aon raised $13.75 billion in senior notes, guaranteed by its subsidiaries, with maturities from 2029 to 2056 and coupons ranging from 5.350% to 6.450%. The funds, approximately $13.4 billion after expenses, will support the USI Advantage Corp. acquisition and general corporate purposes. The notes include redemption protections tied to the deal's completion.